Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HeartSine Technologies is a prominent manufacturer of automated external defibrillators (AEDs) designed for public access and professional use. Founded by Professor John Anderson, a pioneer in portable defibrillation, the company is renowned for its samaritan PAD line of devices, which are characterized by their compact size, ease of use, and high durability. Their proprietary SCOPE (Self-Compensating Output Pulse Envelope) biphasic technology optimizes energy delivery based on patient impedance. Following its acquisition by Physio-Control and subsequently Stryker, HeartSine operates as a key component of Stryker's Emergency Care portfolio. The company's products are distributed globally and are widely used in workplaces, schools, and public spaces to improve survival rates from sudden cardiac arrest.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HeartSine Technologies.